{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:45:07Z","timestamp":1793148307191,"version":"4.5.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Chlamydia trachomatis is one of the most common bacterial sexually transmitted infections worldwide, and is associated with an increased risk of adverse pregnancy outcomes. However, whether providing chlamydia screening and treatment during the first trimester of pregnancy could reduce adverse pregnancy outcomes is still not clear. This study reports a randomized controlled trial (RCT) protocol to evaluate the effectiveness of chlamydia Test and Treat during early pregnancy in preventing adverse pregnancy outcomes in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>This trial is a multi-center two-arm RCT targeting 7,500 pregnant women in early pregnancy (6\u201320 weeks). The inclusion criteria included: 18\u201339 years old, on their first antenatal visit, in the first trimester, and plan to deliver in the study cities. Following a block randomization procedure, every block of twenty women will be randomly assigned in a 1:1 ratio into two arms: (1) a Test and Treat arm in which women receive free chlamydia testing immediately after enrollment and people tested as chlamydia positive will receive standardized treatment and partner treatment; (2) a control arm in which women receive regular prenatal care without receiving testing during the pregnancy period, but collect urine samples and test them after delivery or indicating a chlamydia-related complication during pregnancy happens. The primary outcome is a composite of eight adverse events rate at delivery between two arms, including stillbirth, infant death, spontaneous abortion, preterm labor, low birth weight, premature rupture of membranes, postpartum endometritis, and ectopic pregnancy. Secondary outcomes include the cost-effectiveness of the intervention, the proportion of people tested with chlamydia infection, the proportion of tested-positive patients that received treatment, and the proportion of people who were cured 1 month after the treatment initiation. Urine specimens will be collected and tested for chlamydia by using Nucleic Acid Amplification Test. Data will be analyzed according to the intention-to-treat principle.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This trial will test the hypothesis that early testing and treating of chlamydia can reduce the risk for adverse pregnancy outcomes and may help in developing chlamydia screening guidelines in China and other countries with a similar prevalence of chlamydia infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>Chinese Clinical Trials Registry, ChiCTR2000031549. Registered on April 4, 2020.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1121888","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T15:37:59Z","timestamp":1682609879000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of chlamydia Test and Treat strategy in preventing adverse pregnancy outcomes: protocol for a randomized controlled trial"],"prefix":"10.3389","volume":"11","author":[{"given":"Lijun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"B1","article-title":"Web Annex 1: Key Data at a Glance","volume-title":"Global Progress Report on Hiv, Viral Hepatitis and Sexually Transmitted Infections, 2021.","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/sextrans-2019-053999","article-title":"Pregnancy and fertility-related adverse outcomes associated with chlamydia trachomatis infection: a global systematic review and meta-analysis","volume":"96","author":"Tang","year":"2020","journal-title":"Sex Transm Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMcp1412935","article-title":"Screening for chlamydia trachomatis infections in women","volume":"376","author":"Wiesenfeld","year":"2017","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/0002-9378(90)90815-O","article-title":"Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome","volume":"162","author":"Ryan","year":"1990","journal-title":"Am J Obstet Gynecol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/(SICI)1098-0997(1997)5:1<10::AID-IDOG5>3.0.CO;2-I","article-title":"Double-blind placebo-controlled treatment trial of chlamydia trachomatis endocervical infections in pregnant women","volume":"5","author":"Martin","year":"1997","journal-title":"Infect Dis Obstet Gynecol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1001\/jama.263.23.3160","article-title":"Improved pregnancy outcome following successful treatment of chlamydial infection","volume":"263","author":"Cohen","year":"1990","journal-title":"Jama."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s10995-013-1423-6","article-title":"Maternal chlamydia trachomatis infections and preterm birth:the impact of early detection and eradication during pregnancy","volume":"18","author":"Folger","year":"2014","journal-title":"Matern Child Health J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0020-7292(02)00371-5","article-title":"Effect of treatment for chlamydia trachomatis during pregnancy","volume":"80","author":"Rastogi","year":"2003","journal-title":"Int J Gynaecol Obstet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/0002-9378(90)90632-H","article-title":"Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment","volume":"163","author":"McGregor","year":"1990","journal-title":"Am J Obstet Gynecol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"9315757","DOI":"10.1155\/2016\/9315757","article-title":"Chlamydia trachomatis infection in pregnancy: the global challenge of preventing adverse pregnancy and infant outcomes in sub-saharan africa and asia","volume":"2016","author":"Adachi","year":"2016","journal-title":"Biomed Res Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s12884-022-04836-3","article-title":"Preconception reproductive tract infections status and adverse pregnancy outcomes: a population-based retrospective cohort study","volume":"22","author":"Zeng","year":"2022","journal-title":"BMC Pregn Childbirth."},{"key":"B13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/ofid\/ofab206","article-title":"Prevalence of chlamydia trachomatis among pregnant women, gynecology clinic attendees, and subfertile women in guangdong, china: a cross-sectional survey","volume":"6","author":"Li","year":"2021","journal-title":"Open Forum Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S1473-3099(18)30211-1","article-title":"Adverse pregnancy outcomes due to chlamydia trachomatis","volume":"18","author":"Chen","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B15","unstructured":""},{"key":"B16","unstructured":"HockingJ\n            LowN\n            GuyR\n            LawM\n            DonovanB\n            Meredith\n            Temple-Smith\n          Australian chlamydia control effectiveness pilot (Accept): A Cluster Randomised Controlled Trial of Chlamydia Testing in General Practice (Actrn1260000297022)"},{"key":"B17","volume-title":"Guidelines for the Clinical Diagnosis, Treatment and Prevention of Sexually Transmitted Diseases, Second Edition.","author":"Qianqiu.","year":"2020"},{"key":"B18","doi-asserted-by":"publisher","first-page":"531073","DOI":"10.3389\/fpubh.2021.531073","article-title":"Chlamydia trachomatis screening and treatment in pregnancy to reduce adverse pregnancy and neonatal outcomes: a review","volume":"9","author":"Adachi","year":"2021","journal-title":"Front Public Health."},{"key":"B19","unstructured":"2022"},{"key":"B20","unstructured":"1993"},{"key":"B21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/sti.2006.022665","article-title":"Pregnancy outcomes in women infected with chlamydia trachomatis: a population-based cohort study in Washington State","volume":"83","author":"Blas","year":"2007","journal-title":"Sex Transm Infect."},{"key":"B22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.5935\/1518-0557.20220015","article-title":"Endometritis - diagnosis, treatment and its impact on fertility - a scoping review","volume":"26","author":"Singh","year":"2022","journal-title":"JBRA Assist Reprod."},{"key":"B23","doi-asserted-by":"publisher","first-page":"902","DOI":"10.7326\/M14-1981","article-title":"Screening for chlamydia and gonorrhea: U.S. preventive services task force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S1473-3099(18)30049-5","article-title":"Treating chlamydial infections in pregnancy and preventing adverse birth outcomes","volume":"18","author":"Adamson","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B25","year":"2016","journal-title":"Who Guidelines for the Treatment of Chlamydia Trachomatis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jama.2021.14081","article-title":"Screening for chlamydia and gonorrhea: us preventive services task force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"Jama."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1121888\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T15:38:04Z","timestamp":1682609884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1121888\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":26,"alternative-id":["10.3389\/fpubh.2023.1121888"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1121888","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"article-number":"1121888"}}